Business
Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday – Motley Fool
The FDA delivered a powerful shot of good news to the company.
What happened
Now this is a stock pop. On Thursday, shares of Lexicon Pharmaceutials(NASDAQ:LXRX) jumped 105% (no, that’s not a typo) after the company issued a major positive regulatory update.
So what
The happy news is that Lexicon’s clinical-stage protein inhibitor sotagliflozin performed well enough in phase 3 clinical trials to support a New Drug Application (NDA) from the Food and Drug Administration. This paves the way for sotagliflozin to win approval for treating patients at risk of heart…
-
Business18 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News14 hours agoWilliam Robinson dies aged 89
-
Business18 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Noosa News15 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats